stockrow
Friday 6 November 2026
Export QDEL’s income statement to Excel — free account
QuidelOrtho Corporation
QDEL Healthcare Medical Devices
QuidelOrtho Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 1.89% from fiscal 2024.
- Revenue
- −11.6%
- EPS
- +92.7%
- Free cash flow
- +120.7%
- Total debt
- +10.5%
Quarter to September 2026, against a year earlier
11.23
1.61
−12.54%
Follow QDEL
Alert me
QuidelOrtho Corporation (QDEL) P/E ratio
QuidelOrtho Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 440× (December 2015) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 6.8× | (15.91%) |
| FY2021 | 8.0× | (13.99%) |
| FY2020 | 9.3× | (77.84%) |
| FY2019 | 42.2× | 70.96% |
| FY2018 | 24.7× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 440×
Ten-year median
4.2×
Current reading's percentile
47
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CBLL CeriBell, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| SIBN SiBone compare | n/m |
| QDEL QuidelOrtho Corporation | n/m |
| KIDS OrthoPediatrics Corp. compare | n/m |
| BVS Bioventus Inc. compare | 12.3× |
| IRMD iRadimed Corporation compare | 44.9× |
| IART Integra LifeSciences Holdings Corporation compare | 83.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)